{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:54:38Z","timestamp":1779335678745,"version":"3.51.4"},"reference-count":40,"publisher":"Aging and Disease","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging and disease"],"published-print":{"date-parts":[[2019]]},"DOI":"10.14336\/ad.2018.1120","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T08:13:04Z","timestamp":1544688784000},"page":"746","source":"Crossref","is-referenced-by-count":9,"title":["Increased Serum Matrix Metalloproteinase-9 Levels are Associated with Anti-Jo1 but not Anti-MDA5 in Myositis Patients"],"prefix":"10.14336","volume":"10","author":[{"given":"Yanjuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiyan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyun","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meidong","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siming","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizhi","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Zuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan-Zhen","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huali","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5462","reference":[{"key":"key-10.14336\/AD.2018.1120-1","doi-asserted-by":"crossref","unstructured":"Oldroyd A, Lilleker J, Chinoy H (2017). Idiopathic inflammatory myopathies-a guide to subtypes, diagnostic approach and treatment. Clin Med (Lond), 17: 322-328.","DOI":"10.7861\/clinmedicine.17-4-322"},{"key":"key-10.14336\/AD.2018.1120-2","unstructured":"Targoff IN (1990). Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. J Immunol, 144: 1737-1743."},{"key":"key-10.14336\/AD.2018.1120-3","doi-asserted-by":"crossref","unstructured":"Hane H, Muro Y, Watanabe K, Ogawa Y, Sugiura K, Akiyama M (2014). Establishment of an ELISA to detect anti-glycyl-tRNA synthetase antibody (anti-EJ), a serological marker of dermatomyositis\/polymyositis and interstitial lung disease. Clin Chim Acta, 431: 9-14.","DOI":"10.1016\/j.cca.2014.01.005"},{"key":"key-10.14336\/AD.2018.1120-4","doi-asserted-by":"crossref","unstructured":"Owen CA, Campbell EJ (1999). The cell biology of leukocyte-mediated proteolysis. J Leukoc Biol, 65: 137-150.","DOI":"10.1002\/jlb.65.2.137"},{"key":"key-10.14336\/AD.2018.1120-5","doi-asserted-by":"crossref","unstructured":"Ren C, Li N, Wang B, Yang Y, Gao J, Li S, et al. (2015). Limb Ischemic Perconditioning Attenuates Blood-Brain Barrier Disruption by Inhibiting Activity of MMP-9 and Occludin Degradation after Focal Cerebral Ischemia. Aging Dis, 6: 406-417.","DOI":"10.14336\/AD.2015.0812"},{"key":"key-10.14336\/AD.2018.1120-6","doi-asserted-by":"crossref","unstructured":"Zhao G, Cheng XW, Piao L, Hu L, Lei Y, Yang G, et al. (2017). The Soluble VEGF Receptor sFlt-1 Contributes to Impaired Neovascularization in Aged Mice. Aging Dis, 8: 287-300.","DOI":"10.14336\/AD.2016.0920"},{"key":"key-10.14336\/AD.2018.1120-7","doi-asserted-by":"crossref","unstructured":"Yan T, Venkat P, Chopp M, Zacharek A, Yu P, Ning R, et al. (2018). APX3330 Promotes Neurorestorative Effects after Stroke in Type One Diabetic Rats. Aging Dis, 9: 453-466.","DOI":"10.14336\/AD.2017.1130"},{"key":"key-10.14336\/AD.2018.1120-8","doi-asserted-by":"crossref","unstructured":"Choi YC, Dalakas MC (2000). Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies. Neurology, 54: 65-71.","DOI":"10.1212\/WNL.54.1.65"},{"key":"key-10.14336\/AD.2018.1120-9","doi-asserted-by":"crossref","unstructured":"Kieseier BC, Schneider C, Clements JM, Gearing AJ, Gold R, Toyka KV, et al. (2001). Expression of specific matrix metalloproteinases in inflammatory myopathies. Brain, 124: 341-351.","DOI":"10.1093\/brain\/124.2.341"},{"key":"key-10.14336\/AD.2018.1120-10","doi-asserted-by":"crossref","unstructured":"Liuzzi GM, Trojano M, Fanelli M, Avolio C, Fasano A, Livrea P, et al. (2002). Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis. Mult Scler, 8: 222-228.","DOI":"10.1191\/1352458502ms800oa"},{"key":"key-10.14336\/AD.2018.1120-11","doi-asserted-by":"crossref","unstructured":"Tchetverikov I, Lard LR, DeGroot J, Verzijl N, TeKoppele JM, Breedveld FC, et al. (2003). Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis. Ann Rheum Dis, 62: 1094-1099.","DOI":"10.1136\/ard.62.11.1094"},{"key":"key-10.14336\/AD.2018.1120-12","doi-asserted-by":"crossref","unstructured":"Kim WU, Min SY, Cho ML, Hong KH, Shin YJ, Park SH, et al. (2005). Elevated matrix metalloproteinase-9 in patients with systemic sclerosis. Arthritis Res Ther, 7: R71-79.","DOI":"10.1186\/ar1454"},{"key":"key-10.14336\/AD.2018.1120-13","doi-asserted-by":"crossref","unstructured":"Ainiala H, Hietaharju A, Dastidar P, Loukkola J, Lehtimaki T, Peltola J, et al. (2004). Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities. Arthritis Rheum, 50: 858-865.","DOI":"10.1002\/art.20045"},{"key":"key-10.14336\/AD.2018.1120-14","doi-asserted-by":"crossref","unstructured":"Leclair V, Lundberg IE (2018). New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter. Curr Rheumatol Rep, 20: 18.","DOI":"10.1007\/s11926-018-0726-4"},{"key":"key-10.14336\/AD.2018.1120-15","doi-asserted-by":"crossref","unstructured":"Hall JC, Casciola-Rosen L, Samedy LA, Werner J, Owoyemi K, Danoff SK, et al. (2013). Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum. Arthritis Care Res (Hoboken), 65: 1307-1315.","DOI":"10.1002\/acr.21992"},{"key":"key-10.14336\/AD.2018.1120-16","unstructured":"Karayel F, Pakis I, Akcay Turan A, Oz B, Celik S (2009). [Assessment of smoking related pathologic changes and MMP-9, TIMP-1 expressions of the lung]. Tuberk Toraks, 57: 129-135."},{"key":"key-10.14336\/AD.2018.1120-17","doi-asserted-by":"crossref","unstructured":"Palterer B, Vitiello G, Carraresi A, Giudizi MG, Cammelli D, Parronchi P (2018). Bench to bedside review of myositis autoantibodies. Clin Mol Allergy, 16: 5.","DOI":"10.1186\/s12948-018-0084-9"},{"key":"key-10.14336\/AD.2018.1120-18","doi-asserted-by":"crossref","unstructured":"Huang Y, Cai GQ, Peng JP, Shen C (2018). Glucocorticoids induce apoptosis and matrix metalloproteinase-13 expression in chondrocytes through the NOX4\/ROS\/p38 MAPK pathway. J Steroid Biochem Mol Biol.","DOI":"10.1016\/j.jsbmb.2018.03.001"},{"key":"key-10.14336\/AD.2018.1120-19","doi-asserted-by":"crossref","unstructured":"Yousaf MN, Powell MD (2012). The effects of heart and skeletal muscle inflammation and cardiomyopathy syndrome on creatine kinase and lactate dehydrogenase levels in Atlantic salmon (Salmo salar L.). Scientific World Journal, 2012: 741302.","DOI":"10.1100\/2012\/741302"},{"key":"key-10.14336\/AD.2018.1120-20","doi-asserted-by":"crossref","unstructured":"Gusella M, Bolzonella C, Paolini R, Rodella E, Bertolaso L, Scipioni C, et al. (2017). Plasma matrix metalloprotease 9 correlates with blood lymphocytosis, leukemic cell invasiveness, and prognosis in B-cell chronic lymphocytic leukemia. Tumour Biol, 39: 1010428317694325.","DOI":"10.1177\/1010428317694325"},{"key":"key-10.14336\/AD.2018.1120-21","doi-asserted-by":"crossref","unstructured":"Maisi P, Prikk K, Sepper R, Pirila E, Salo T, Hietanen J, et al. (2002). Soluble membrane-type 1 matrix metalloproteinase (MT1-MMP) and gelatinase A (MMP-2) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis. Apmis, 110: 771-782.","DOI":"10.1034\/j.1600-0463.2002.1101102.x"},{"key":"key-10.14336\/AD.2018.1120-22","doi-asserted-by":"crossref","unstructured":"Devarajan P, Johnston JJ, Ginsberg SS, Van Wart HE, Berliner N (1992). Structure and expression of neutrophil gelatinase cDNA. Identity with type IV collagenase from HT1080 cells. J Biol Chem, 267: 25228-25232.","DOI":"10.1016\/S0021-9258(19)74029-0"},{"key":"key-10.14336\/AD.2018.1120-23","doi-asserted-by":"crossref","unstructured":"Riani M, Le Jan S, Plee J, Durlach A, Le Naour R, Haegeman G, et al. (2017). Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes. J Allergy Clin Immunol, 139: 863-872 e863.","DOI":"10.1016\/j.jaci.2016.08.012"},{"key":"key-10.14336\/AD.2018.1120-24","doi-asserted-by":"crossref","unstructured":"Gossage DL, Cieslarova B, Ap S, Zheng H, Xin Y, Lal P, et al. (2018). Phase 1b Study of the Safety, Pharmacokinetics, and Disease-related Outcomes of the Matrix Metalloproteinase-9 Inhibitor Andecaliximab in Patients With Rheumatoid Arthritis. Clin Ther, 40: 156-165.e155.","DOI":"10.1016\/j.clinthera.2017.11.011"},{"key":"key-10.14336\/AD.2018.1120-25","doi-asserted-by":"crossref","unstructured":"Ertugrul G, Keles D, Oktay G, Aktan S (2018). Matrix metalloproteinase-2 and -9 activity levels increase in cutaneous lupus erythematosus lesions and correlate with disease severity. Arch Dermatol Res, 310: 173-179.","DOI":"10.1007\/s00403-018-1811-2"},{"key":"key-10.14336\/AD.2018.1120-26","doi-asserted-by":"crossref","unstructured":"Ram M, Sherer Y, Shoenfeld Y (2006). Matrix metalloproteinase-9 and autoimmune diseases. J Clin Immunol, 26: 299-307.","DOI":"10.1007\/s10875-006-9022-6"},{"key":"key-10.14336\/AD.2018.1120-27","doi-asserted-by":"crossref","unstructured":"Lemjabbar H, Gosset P, Lamblin C, Tillie I, Hartmann D, Wallaert B, et al. (1999). Contribution of 92 kDa gelatinase\/type IV collagenase in bronchial inflammation during status asthmaticus. Am J Respir Crit Care Med, 159: 1298-1307.","DOI":"10.1164\/ajrccm.159.4.9708080"},{"key":"key-10.14336\/AD.2018.1120-28","doi-asserted-by":"crossref","unstructured":"Gerwien H, Hermann S, Zhang X, Korpos E, Song J, Kopka K, et al. (2016). Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrier. Sci Transl Med, 8: 364ra152.","DOI":"10.1126\/scitranslmed.aaf8020"},{"key":"key-10.14336\/AD.2018.1120-29","doi-asserted-by":"crossref","unstructured":"Rodolico C, Mazzeo A, Toscano A, Messina S, Aguennouz M, Gaeta M, et al. (2005). Specific matrix metalloproteinase expression in focal myositis: an immunopathological study. Acta Neurol Scand, 112: 173-177.","DOI":"10.1111\/j.1600-0404.2005.00457.x"},{"key":"key-10.14336\/AD.2018.1120-30","doi-asserted-by":"crossref","unstructured":"Kim Y, Remacle AG, Chernov AV, Liu H, Shubayev I, Lai C, et al. (2012). The MMP-9\/TIMP-1 axis controls the status of differentiation and function of myelin-forming Schwann cells in nerve regeneration. PLoS One, 7: e33664.","DOI":"10.1371\/journal.pone.0033664"},{"key":"key-10.14336\/AD.2018.1120-31","doi-asserted-by":"crossref","unstructured":"Cauwe B, Opdenakker G (2010). Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases. Crit Rev Biochem Mol Biol, 45: 351-423.","DOI":"10.3109\/10409238.2010.501783"},{"key":"key-10.14336\/AD.2018.1120-32","doi-asserted-by":"crossref","unstructured":"Mimori T, Nakashima R, Hosono Y (2012). Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment. Curr Rheumatol Rep, 14: 264-274.","DOI":"10.1007\/s11926-012-0246-6"},{"key":"key-10.14336\/AD.2018.1120-33","doi-asserted-by":"crossref","unstructured":"Nakashima R, Imura Y, Kobayashi S, Yukawa N, Yoshifuji H, Nojima T, et al. (2010). The RIG-I-like receptor IFIH1\/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford), 49: 433-440.","DOI":"10.1093\/rheumatology\/kep375"},{"key":"key-10.14336\/AD.2018.1120-34","doi-asserted-by":"crossref","unstructured":"Labirua A, Lundberg IE (2010). Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Curr Opin Rheumatol, 22: 633-638.","DOI":"10.1097\/BOR.0b013e32833f1970"},{"key":"key-10.14336\/AD.2018.1120-35","doi-asserted-by":"crossref","unstructured":"Targoff IN (2000). Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol, 12: 475-481.","DOI":"10.1097\/00002281-200011000-00001"},{"key":"key-10.14336\/AD.2018.1120-36","doi-asserted-by":"crossref","unstructured":"Gono T, Kawaguchi Y, Ozeki E, Ota Y, Satoh T, Kuwana M, et al. (2011). Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis. Mod Rheumatol, 21: 223-227.","DOI":"10.3109\/s10165-010-0371-x"},{"key":"key-10.14336\/AD.2018.1120-37","doi-asserted-by":"crossref","unstructured":"Hoshino K, Muro Y, Sugiura K, Tomita Y, Nakashima R, Mimori T (2010). Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis. Rheumatology (Oxford), 49: 1726-1733.","DOI":"10.1093\/rheumatology\/keq153"},{"key":"key-10.14336\/AD.2018.1120-38","doi-asserted-by":"crossref","unstructured":"Gono T, Kawaguchi Y, Satoh T, Kuwana M, Katsumata Y, Takagi K, et al. (2010). Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford), 49: 1713-1719.","DOI":"10.1093\/rheumatology\/keq149"},{"key":"key-10.14336\/AD.2018.1120-39","doi-asserted-by":"crossref","unstructured":"Fujikawa K, Kawakami A, Kaji K, Fujimoto M, Kawashiri S, Iwamoto N, et al. (2009). Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155\/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study. Scand J Rheumatol, 38: 263-267.","DOI":"10.1080\/03009740802687455"},{"key":"key-10.14336\/AD.2018.1120-40","doi-asserted-by":"crossref","unstructured":"Gono T, Sato S, Kawaguchi Y, Kuwana M, Hanaoka M, Katsumata Y, et al. (2012). Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Rheumatology (Oxford), 51: 1563-1570.","DOI":"10.1093\/rheumatology\/kes102"}],"container-title":["Aging and disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.aginganddisease.org\/fileup\/2152-5250\/PDF\/ad-0-0-0-1811261242-1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T03:24:43Z","timestamp":1627529083000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2018.1120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.14336\/ad.2018.1120","relation":{},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}